IMPACT SCORE JOURNAL RANKING CONFERENCE RANKING Conferences Journals Workshops Seminars SYMPOSIUMS MEETINGS BLOG LaTeX 5G Tutorial Free Tools

Search About Journals, Conferences, and Book Series

Clinical and Experimental Metastasis

Impact, Factor and Metrics, Impact Score, Ranking, h-index, SJR, Rating, Publisher, ISSN, and More

Last Updated on September 3, 2024

Impact Score

2023-2024

3.99

h-Index

2023-2024

 109

Rank

2023-2024

 3223

SJR

2023-2024

 1.216

Note: The impact score or impact index shown here is equivalent to the average number of times documents published in a journal/conference in the past two years have been cited in the current year (i.e., Cites / Doc. (2 years)). It is based on Scopus data and can be a little higher or different compared to the impact factor (IF) produced by Journal Citation Report. Please refer to the Web of Science data source to check the exact journal impact factor ™ (Thomson Reuters) metric.

Important Metrics and Factor

Title Clinical and Experimental Metastasis
Abbreviation Clin. Exp. Metastasis
Publication Type Journal
Subject Area, Categories, Scope Medicine (miscellaneous) (Q1); Oncology (Q1); Cancer Research (Q2)
h-index 109
Overall Rank/Ranking 3223
SCImago Journal Rank (SJR) 1.216
Impact Score 3.99
Publisher Springer Netherlands
Country Netherlands
ISSN 02620898, 15737276
Best Quartile Q1
Coverage History 1983-2023




Aim and Scope


Clinical & Experimental Metastasis is an international, multidisciplinary journal devoted to the rapid publication of fundamental advances in basic and applied metastasis research.
The coverage encompasses all aspects of metastasis research, whether laboratory-based, experimental or clinical and therapeutic. It includes such areas as molecular biology, pharmacology, tumour biology, and clinical cancer treatment (with all its subdivisions of surgery, chemotherapy and radio-therapy as well as pathology and epidemiology) insofar as these disciplines are concerned with the journal core subject of metastasis formation, prevention and treatment.
Clinical & Experimental Metastasis is the official journal of the Metastasis Research Society.


About Clinical and Experimental Metastasis


Clinical and Experimental Metastasis is a journal covering the technologies/fields/categories related to Medicine (miscellaneous) (Q1); Oncology (Q1); Cancer Research (Q2). It is published by Springer Netherlands. The overall rank of Clinical and Experimental Metastasis is 3223. According to SCImago Journal Rank (SJR), this journal is ranked 1.216. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come. SJR acts as an alternative to the Journal Impact Factor (or an average number of citations received in last 2 years). This journal has an h-index of 109. The best quartile for this journal is Q1.

The ISSN of Clinical and Experimental Metastasis journal is 02620898, 15737276. An International Standard Serial Number (ISSN) is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic. Clinical and Experimental Metastasis is cited by a total of 711 articles during the last 3 years (Preceding 2023).


Clinical and Experimental Metastasis Impact IF 2023-2024


The Impact IF 2023 of Clinical and Experimental Metastasis is 3.99, which is computed in 2024 as per its definition. Clinical and Experimental Metastasis IF is increased by a factor of 0.25 and approximate percentage change is 6.68% when compared to preceding year 2022, which shows a rising trend. The impact IF, also denoted as Journal impact score (JIS), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal. It is based on Scopus data.

Table Setting

Clinical and Experimental Metastasis Impact IF 2024 Prediction


Impact IF 2023 of Clinical and Experimental Metastasis is 3.99. If the same upward trend persists, Impact IF may rise in 2024 as well.


Impact IF Trend


Year wise Impact IF of Clinical and Experimental Metastasis. Based on Scopus data.


Year Impact IF
2023/2024 Coming Soon
2023 3.99
2022 3.74
2021 4.04
2020 4.31
2019 2.76
2018 2.48
2017 3.57
2016 3.36
2015 3.15
2014 3.75

Clinical and Experimental Metastasis h-index


  Table Setting

Clinical and Experimental Metastasis has an h-index of 109. It means 109 articles of this journal have more than 109 number of citations. The h-index is a way of measuring the productivity and citation impact of the publications. The h-index is defined as the maximum value of h such that the given journal/author has published h papers that have each been cited at least h number of times.




Clinical and Experimental Metastasis ISSN


The ISSN of Clinical and Experimental Metastasis is 02620898, 15737276. ISSN stands for International Standard Serial Number.

An ISSN is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic.

Table Setting

Clinical and Experimental Metastasis Rank and SCImago Journal Rank (SJR)


The overall rank of Clinical and Experimental Metastasis is 3223. According to SCImago Journal Rank (SJR), this journal is ranked 1.216. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come.

SJR of Clinical and Experimental Metastasis by Year


Year SJR
2023/2024 Coming Soon
2023 1.216
2022 1.125
2021 1.108
2020 1.269
2019 1.340
2018 1.229
2017 1.397
2016 1.299
2015 1.341
2014 1.947

Ranking of Clinical and Experimental Metastasis by Year


Year Ranking
2023/2024 Coming Soon
2023 3223
2022 3457
2021 3480
2020 3005
2019 2714
2018 3199
2017 2605
2016 2961
2015 2865
2014 1472

Clinical and Experimental Metastasis Publisher


Table Setting

Clinical and Experimental Metastasis is published by Springer Netherlands. It's publishing house is located in Netherlands. Coverage history of this journal is as following: 1983-2023. The organization or individual who handles the printing and distribution of printed or digital publications is known as Publisher.


Call For Papers


Visit the official website of the journal/conference to check the further details about the call for papers.


Abbreviation


The IS0 4 standard abbreviation of Clinical and Experimental Metastasis is Clin. Exp. Metastasis. This abbreviation ('Clin. Exp. Metastasis') is well recommended and approved for the purpose of indexing, abstraction, referencing and citing goals. It meets all the essential criteria of ISO 4 standard.

ISO 4 (International Organization for Standardization 4) is an international standard that defines a uniform and consistent system for abbreviating serial publication titles and journals.


How to publish in Clinical and Experimental Metastasis


If your research field is/are related to Medicine (miscellaneous) (Q1); Oncology (Q1); Cancer Research (Q2), then please visit the official website of this journal.


Acceptance Rate


The acceptance rate/percentage of any academic journal/conference depends upon many parameters. Some of the critical parameters are listed below.

  • The demand or interest of researchers/scientists in publishing in a specific Journal/Conference.
  • Peer review complexity and timeline.
  • The mix of unsolicited and invited submissions.
  • The time it takes from manuscript submission to final publication.
  • And Many More.

It is essential to understand that the acceptance rate/rejection rate of papers varies among journals. Some Journals considers all the manuscripts submissions as a basis of acceptance rate computation. On the other hand, few consider the only manuscripts sent for peer review or few even not bother about the accurate maintenance of total submissions. Hence, it can provide a rough estimation only.

The best way to find out the acceptance rate is to reach out to the associated editor or to check the official website of the Journal/Conference.



Frequently Asked Questions (FAQs)


What's the latest impact IF of the Clinical and Experimental Metastasis?

Clinical and Experimental Metastasis latest impact IF is 3.99. It's evaluated in the year 2023. The highest and the lowest impact IF or impact score of this journal are 4.31 (2020) and 2.48 (2018), respectively, in the last 10 years. Moreover, its average IS is 3.52 in the previous 10 years.


What's the SCImago Journal Rank (SJR) of the Clinical and Experimental Metastasis?

The Clinical and Experimental Metastasis has an SJR (SCImago Journal Rank) of 1.216, according to the latest data. It is computed in the year 2024. In the past 10 years, this journal has recorded a range of SJR, with the highest being 1.947 in 2014 and the lowest being 1.108 in 2021. Furthermore, the average SJR of the Clinical and Experimental Metastasis over the previous 10-year period stands at 3.52.


What's the latest h-index of the Clinical and Experimental Metastasis?

The latest h-index of the Clinical and Experimental Metastasis is 109.


Who's the publisher of the Clinical and Experimental Metastasis?

The Clinical and Experimental Metastasis is published by the Springer Netherlands, with its country of publication being the Netherlands.


What's the current ranking of the Clinical and Experimental Metastasis?

The Clinical and Experimental Metastasis is currently ranked 3223 out of 27955 Journals, Conferences, and Book Series in the latest ranking. Over the course of the last 10 years, this journal has experienced varying rankings, reaching its highest position of 1472 in 2014 and its lowest position of 3480 in 2021.


What's the abbreviation or short name for the Clinical and Experimental Metastasis?

The standard ISO4 abbreviation for the Clinical and Experimental Metastasis is Clin. Exp. Metastasis.


Is the "Clinical and Experimental Metastasis" classified as a Journal, Conference and Proceedings, Trade Journal or Book Series?

Clinical and Experimental Metastasis is classified as a journal that the Springer Netherlands publishes.


What's the scope or major areas of the Clinical and Experimental Metastasis?

The Clinical and Experimental Metastasis encompasses the following areas:

  • Medicine (miscellaneous)
  • Oncology
  • Cancer Research

For a more comprehensive understanding of its scope, check the official website of this journal.


What's the ISSN of the Clinical and Experimental Metastasis?

The Clinical and Experimental Metastasis is assigned the following International Standard Serial Numbers (ISSN): 02620898, 15737276.


What's the best quartile of the Clinical and Experimental Metastasis?

The best quartile for the Clinical and Experimental Metastasis is Q1 (2023).


What's the coverage history of the Clinical and Experimental Metastasis?

The Clinical and Experimental Metastasis coverage history can be summarized as follows: 1983-2023.


Credits and Sources


  • Scimago Journal & Country Rank (SJR), https://www.scimagojr.com/
  • Journal Impact Factor, https://clarivate.com/



Impact Score, h-Index, and Other Important Details of These Journals, Conferences, and Books


Journal/Conference/Workshop/Book Title Type Ranking Publisher h-index Impact Score
Proceedings of the Spring Technical Conference of the ASME Internal Combustion Engine Division conference and proceedings 17477 16 0.00
Criminal Justice Review journal 12054 SAGE Publications Inc. 42 1.10
International Journal of Mathematical Education in Science and Technology journal 8417 Taylor and Francis Ltd. 42 1.17
Discourse journal 6196 Routledge 65 2.36
International Journal of Applied Linguistics journal 6241 Wiley-Blackwell Publishing Ltd 53 1.91
Sex Education journal 7722 Routledge 45 2.66
SPE International Formation Damage Control Symposium Proceedings conference and proceedings 21934 16 0.00
Journal of Sociology journal 5238 SAGE Publications Ltd 62 2.22
Perspectives in health information management / AHIMA, American Health Information Management Association journal 13267 American Health Information Management Association 31 1.32
Expert Review of Obstetrics and Gynecology journal 17060 Expert Reviews Ltd. 21 0.00

Check complete list




Year wise Impact Score (IS) of Clinical and Experimental Metastasis

Impact Score Table

Year Impact Score (IS)
2024/2025 Coming Soon
2023 3.99
2022 3.74
2021 4.04
2020 4.31
2019 2.76
2018 2.48
2017 3.57
2016 3.36
2015 3.15
2014 3.75



Top Journals/Conferences in Medicine (miscellaneous)

Nature Reviews Drug Discovery
Nature Publishing Group | United Kingdom

New England Journal of Medicine
Massachussetts Medical Society | United States

Nature Medicine
Nature Research | United Kingdom

Current Protocols in Bioinformatics
John Wiley & Sons Inc. | United States

MMWR supplements
Epidemiology Program Office | United States

Nature Reviews Immunology
Nature Publishing Group | United Kingdom

MMWR Recommendations and Reports
Centers for Disease Control and Prevention (CDC) | United States

Annals of Oncology
Elsevier Ltd | United Kingdom

Morbidity and Mortality Weekly Report
Department of Health and Human Services | United States

Nature Reviews Methods Primers
Springer Nature | United States

See All

Top Journals/Conferences in Oncology

Ca-A Cancer Journal for Clinicians
Wiley-Blackwell | United States

Nature Reviews Cancer
Nature Publishing Group | United Kingdom

Nature Reviews Clinical Oncology
Nature Publishing Group | United Kingdom

Cancer Cell
Cell Press | United States

Annals of Oncology
Elsevier Ltd | United Kingdom

Lancet Oncology, The
Elsevier Ltd | United Kingdom

Nature Cancer
Nature Research | United States

Journal of Clinical Oncology
Lippincott Williams and Wilkins Ltd. | United States

Molecular Cancer
BioMed Central Ltd | United Kingdom

Journal of Thoracic Oncology
Elsevier Inc. | United States

See All

Top Journals/Conferences in Cancer Research

Nature Reviews Cancer
Nature Publishing Group | United Kingdom

Cancer Cell
Cell Press | United States

Nature Cancer
Nature Research | United States

Journal of Clinical Oncology
Lippincott Williams and Wilkins Ltd. | United States

Signal Transduction and Targeted Therapy
Springer Nature | United Kingdom

Molecular Cancer
BioMed Central Ltd | United Kingdom

JAMA Oncology
American Medical Association | United States

Cell Host and Microbe
Cell Press | United States

Journal of Hematology and Oncology
BioMed Central Ltd | United Kingdom

Neuro-Oncology
Oxford University Press | United Kingdom

See All